ATE491726T1 - Antikörper modulierende die biologische aktivität von pferd-choriongonadotropin - Google Patents

Antikörper modulierende die biologische aktivität von pferd-choriongonadotropin

Info

Publication number
ATE491726T1
ATE491726T1 AT04292296T AT04292296T ATE491726T1 AT E491726 T1 ATE491726 T1 AT E491726T1 AT 04292296 T AT04292296 T AT 04292296T AT 04292296 T AT04292296 T AT 04292296T AT E491726 T1 ATE491726 T1 AT E491726T1
Authority
AT
Austria
Prior art keywords
chorionic gonadotropin
biological activity
modulating
antibodies
horse
Prior art date
Application number
AT04292296T
Other languages
English (en)
Inventor
Marie-Christine Maurel
Francois Roy
Virginie Herve
Jean Bertin
Florian Guillou
Original Assignee
Agronomique Inst Nat Rech
Centre Nat Rech Scient
Univ Francois Rabelais De Tours
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agronomique Inst Nat Rech, Centre Nat Rech Scient, Univ Francois Rabelais De Tours filed Critical Agronomique Inst Nat Rech
Application granted granted Critical
Publication of ATE491726T1 publication Critical patent/ATE491726T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Reproductive Health (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT04292296T 2003-09-26 2004-09-24 Antikörper modulierende die biologische aktivität von pferd-choriongonadotropin ATE491726T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03292365 2003-09-26

Publications (1)

Publication Number Publication Date
ATE491726T1 true ATE491726T1 (de) 2011-01-15

Family

ID=34924283

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04292296T ATE491726T1 (de) 2003-09-26 2004-09-24 Antikörper modulierende die biologische aktivität von pferd-choriongonadotropin

Country Status (5)

Country Link
EP (1) EP1518863B1 (de)
AT (1) ATE491726T1 (de)
DE (1) DE602004030524D1 (de)
ES (1) ES2371465T3 (de)
PL (1) PL1518863T3 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2967676B1 (fr) 2010-11-19 2014-09-19 Agronomique Inst Nat Rech Ligand d'hormone luteinisante et complexe ligand-gonadotrophine
FR3025517B1 (fr) 2014-09-10 2016-12-23 Repropharm Ligands potentialisants de la bioactivite des gonadotrophines
CN111596073B (zh) * 2020-06-04 2023-05-02 昆明天沃生物科技有限公司 一种检测羊早期妊娠的方法
EP4563595A1 (de) 2023-11-28 2025-06-04 Igyxos Humanisierte varianten antikörper oder fragmente davon zur erhöhung der gonadotropin-bioaktivität

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0265156A3 (de) * 1986-10-14 1990-08-29 Bunge (Australia) Proprietary Limited Monoklonale Antikörper
CA2183564C (en) * 1994-02-18 2010-07-13 William R. Moyle Methods for altering fertility

Also Published As

Publication number Publication date
PL1518863T3 (pl) 2011-05-31
EP1518863A1 (de) 2005-03-30
EP1518863B1 (de) 2010-12-15
DE602004030524D1 (de) 2011-01-27
ES2371465T3 (es) 2012-01-03

Similar Documents

Publication Publication Date Title
ES2162917T3 (es) Mejoras en o relativas al suministro de peptidos.
DE69535260D1 (de) Verwendung eines nicht-neutralisierenden Antikörpers spezifisch für die beta-Untereinheit von luteinisierendem Hormon zur Erhöhung der Fertilität
DE69840334D1 (de) Puffern zur stabilizierung von hcv antigenen
BG104828A (en) Fap alpha-specific antibody with improved pruducibility
HUP0100681A1 (hu) Diszulfidkötésekkel keresztkötött glikoproteinhormon-analógok, előállításuk és alkalmazásuk
EP1204321A4 (de) Superaktive, wachstumshormone freisetzende hormonanaloge vom schwein
EA200400427A1 (ru) Применение человеческого хорионического гонадотропина и лютеинизирующего гормона при контролируемой гиперстимуляции яичников
IT1197570B (it) Miscele di fsh e lh da ipofisi porcine in rapporto definito
NO904023D0 (no) Blanding som induserer binding.
WO2002085311A3 (en) Hcg formulation
DE602004030524D1 (de) Antikörper modulierende die biologische Aktivität von Pferd-Choriongonadotropin
MY141459A (en) Recombinant anti-idiotypic antibodies
CA2008817A1 (en) M-csf monoclonal antibodies that recognize a neutralizing conformational epitope
ATE65407T1 (de) Verfahren zur herbeifuehrung der ovulation.
PT93178A (pt) Agente proteico anticanceroso
NO20000731L (no) Neisseria lactoferinbindingsprotein
RU2003120100A (ru) Способ прогнозирования фетоплацентарной недостаточности
ATE512985T1 (de) Diagnostische und therapeutische anwendungen von löslichem lhcgr-protein
RU2002112768A (ru) Способ сорбционно-фотометрического определения золота (111)
Lipsitz Pregnancy Tests.
ZA91699B (en) Antibodies specifically recognizing somatotropin binding protein
WO2002095413A3 (en) Diagnosis of vascular disease susceptibility using bacteriophage phi-cpn1 host chlamydia
ATE429489T1 (de) Menschliche carnosinase 2
DE69032996D1 (de) Rekombinanter impfstoff zur geburtenkontrolle
ATE474059T1 (de) Mittel und methoden um die entwicklung und reifung von fisch eizellen oder spermien zu fördern durch verabreichung von durch transplantierten zellen produzierten hormonen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties